{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:00:20Z","timestamp":1781650820410,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundamental Research Funds for the Central Universities, Peking Union Medical College","award":["3332025184"],"award-info":[{"award-number":["3332025184"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2023-PUMCH-F-004"],"award-info":[{"award-number":["2023-PUMCH-F-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49341-1","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:36:37Z","timestamp":1776868597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hsa_circ_0002111 implicates KTC-1 cell motility and modulates migration and invasion via miR-432-5p\/CDKN2B axis"],"prefix":"10.1038","volume":"16","author":[{"given":"Fangyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"49341_CR1","first-page":"425","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai, L., Zafereo, M. & Cabanillas, M. E. Thyroid Cancer: Rev. Jama 331, 425\u2013435, (2024).","journal-title":"Thyroid Cancer: Rev. Jama"},{"key":"49341_CR2","doi-asserted-by":"publisher","first-page":"1598934","DOI":"10.3389\/fonc.2025.1598934","volume":"15","author":"M Li","year":"2025","unstructured":"Li, M., Li, Q., Zou, C., Huang, Q. & Chen, Y. Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma. Front. Oncol. 15, 1598934 (2025).","journal-title":"Front. Oncol."},{"key":"49341_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-981-96-9428-0_16","volume":"1485","author":"A Greasley","year":"2025","unstructured":"Greasley, A., Li, S., Liu, K. & Zheng, X. CircRNA Synthesis and Applications. Adv. Exp. Med. Biol. 1485, 241\u2013252 (2025).","journal-title":"Adv. Exp. Med. Biol."},{"key":"49341_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng, S. et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol. Cancer. 16, 94 (2017).","journal-title":"Mol. Cancer"},{"key":"49341_CR5","doi-asserted-by":"publisher","first-page":"e37089","DOI":"10.1016\/j.heliyon.2024.e37089","volume":"10","author":"M Shahpari","year":"2024","unstructured":"Shahpari, M. et al. The functional roles of competitive endogenous RNA (ceRNA) networks in apoptosis in human cancers: The circRNA\/miRNA\/mRNA regulatory axis and cell signaling pathways. Heliyon 10, e37089 (2024).","journal-title":"Heliyon"},{"key":"49341_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384\u2013388 (2013).","journal-title":"Nature"},{"key":"49341_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-018-0936-7","volume":"37","author":"W Bi","year":"2018","unstructured":"Bi, W. et al. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of \u03b2-catenin pathway. J. Exp. Clin. Cancer Res. 37, 275 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"49341_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41420-021-00798-1","volume":"8","author":"D Zhang","year":"2022","unstructured":"Zhang, D. et al. CircRNA circTIAM1 promotes papillary thyroid cancer progression through the miR-646\/HNRNPA1 signaling pathway. Cell. Death Discov. 8, 21 (2022).","journal-title":"Cell. Death Discov"},{"key":"49341_CR9","doi-asserted-by":"publisher","first-page":"2244515","DOI":"10.1080\/07853890.2023.2244515","volume":"55","author":"B Wang","year":"2023","unstructured":"Wang, B. et al. Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer. Ann. Med. 55, 2244515 (2023).","journal-title":"Ann. Med."},{"key":"49341_CR10","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.7150\/ijbs.55381","volume":"17","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. The emerging function and clinical significance of circRNAs in Thyroid Cancer and Autoimmune Thyroid Diseases. Int. J. Biol. Sci. 17, 1731\u20131741 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"49341_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/or.2020.7626","volume":"44","author":"D Guo","year":"2020","unstructured":"Guo, D. et al. Circular RNA expression and association with the clinicopathological characteristics in papillary thyroid carcinoma. Oncol. Rep. 44, 519\u2013532 (2020).","journal-title":"Oncol. Rep."},{"key":"49341_CR12","doi-asserted-by":"publisher","first-page":"644011","DOI":"10.3389\/fonc.2021.644011","volume":"11","author":"G Du","year":"2021","unstructured":"Du, G. et al. Increased Expression of hsa_circ_0002111 and Its Clinical Significance in Papillary Thyroid Cancer. Front. Oncol. 11, 644011 (2021).","journal-title":"Front. Oncol."},{"key":"49341_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/10799893.2021.1910706","volume":"42","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p\/METTL7B axis. J. Recept Signal. Transduct. Res. 42, 251\u2013260 (2022).","journal-title":"J. Recept Signal. Transduct. Res."},{"key":"49341_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12943-023-01882-z","volume":"22","author":"L Xu","year":"2023","unstructured":"Xu, L. et al. circPSD3 is a promising inhibitor of uPA system to inhibit vascular invasion and metastasis in hepatocellular carcinoma. Mol. Cancer. 22, 174 (2023).","journal-title":"Mol. Cancer"},{"key":"49341_CR15","doi-asserted-by":"crossref","unstructured":"Xie, X. et al. Downregulation of circular RNA circPSD3 promotes metastasis by modulating FBXW7 expression in clear cell renal cell carcinoma. J. Oncol. 2022 5084631, (2022).","DOI":"10.1155\/2022\/5084631"},{"key":"49341_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40618-022-01921-4","volume":"46","author":"H Zhang","year":"2023","unstructured":"Zhang, H., Jiang, J., He, X. & Zhou, Q. Circ_0002111\/miR-134-5p\/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells. J. Endocrinol. Invest. 46, 713\u2013725 (2023).","journal-title":"J. Endocrinol. Invest."},{"key":"49341_CR17","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1097\/CAD.0000000000001382","volume":"33","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p\/HMGB1 axis. Anticancer Drugs. 33, 923\u2013934 (2022).","journal-title":"Anticancer Drugs"},{"key":"49341_CR18","doi-asserted-by":"crossref","unstructured":"Li, C. et al. BRAF regulates circPSD3\/miR-526b\/RAP2A axis to hinder papillary thyroid carcinoma progression. BMC Mol. Cell. Biol. 26, 6. (2025).","DOI":"10.1186\/s12860-024-00528-2"},{"key":"49341_CR19","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","volume":"43","author":"J Zhao","year":"2024","unstructured":"Zhao, J. et al. Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer. Oncogene 43, 2104\u20132114 (2024).","journal-title":"Oncogene"},{"key":"49341_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12935-024-03301-9","volume":"24","author":"CH Chou","year":"2024","unstructured":"Chou, C. H. et al. The upregulation of VGF enhances the progression of oral squamous carcinoma. Cancer Cell. Int. 24, 115 (2024).","journal-title":"Cancer Cell. Int."},{"key":"49341_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41388-024-02956-y","volume":"43","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability. Oncogene 43, 976\u2013991 (2024).","journal-title":"Oncogene"},{"key":"49341_CR22","doi-asserted-by":"publisher","first-page":"e00410","DOI":"10.1016\/j.plabm.2024.e00410","volume":"40","author":"N Kiatprungvech","year":"2024","unstructured":"Kiatprungvech, N. et al. Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients. Pract. Lab. Med. 40, e00410 (2024).","journal-title":"Pract. Lab. Med."},{"key":"49341_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000513338","volume":"88","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. Long Noncoding RNA GAS5 Targeting miR-221-3p\/Cyclin-Dependent Kinase Inhibitor 2B Axis Regulates Follicular Thyroid Carcinoma Cell Cycle and Proliferation. Pathobiology 88, 289\u2013300 (2021).","journal-title":"Pathobiology"},{"key":"49341_CR24","doi-asserted-by":"crossref","unstructured":"Wu, Q. et al. Cancer stem cell-like cells-derived exosomal CDKN2B-AS1 stabilizes CDKN2B to promote the growth and metastasis of thyroid cancer via TGF-\u03b21\/Smad2\/3 signaling. Exp. Cell. Res. 419, 113268.  (2022).","DOI":"10.1016\/j.yexcr.2022.113268"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49341-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49341-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:03Z","timestamp":1781650083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49341-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49341"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49341-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18751"}}